Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Symbio Pharmaceuticals Limited (JP:4582)
TSE/TYO:4582
Holding JP:4582?
Track your performance easily
4582 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥146.00 - ¥475.00
Previous Close¥248
Volume563.00K
Average Volume (3M)4.87M
Market Cap
¥11.37B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.57
Next Earnings
Nov 21, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-81.43
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume4,869,214
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Symbio Pharmaceuticals Limited News
PremiumCompany Announcements
Symbio Pharmaceuticals Faces Steep Decline in H1 FY2024Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
0.16% Other Institutional Investors
99.84% Public Companies and
Individual Investors
4582 FAQ
What was Symbio Pharmaceuticals Limited’s price range in the past 12 months?
Symbio Pharmaceuticals Limited lowest stock price was ¥146.00 and its highest was ¥475.00 in the past 12 months.
What is Symbio Pharmaceuticals Limited’s market cap?
Currently, no data Available
When is Symbio Pharmaceuticals Limited’s upcoming earnings report date?
Symbio Pharmaceuticals Limited’s upcoming earnings report date is Nov 21, 2024 which is in 62 days.
How were Symbio Pharmaceuticals Limited’s earnings last quarter?
Symbio Pharmaceuticals Limited released its earnings results on Aug 01, 2024. The company reported -¥16.72 earnings per share for the quarter, missing the consensus estimate of N/A by -¥16.72.
Is Symbio Pharmaceuticals Limited overvalued?
According to Wall Street analysts Symbio Pharmaceuticals Limited’s price is currently Overvalued.
Does Symbio Pharmaceuticals Limited pay dividends?
Symbio Pharmaceuticals Limited does not currently pay dividends.
What is Symbio Pharmaceuticals Limited’s EPS estimate?
Symbio Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Symbio Pharmaceuticals Limited have?
Symbio Pharmaceuticals Limited has 45,910,080 shares outstanding.
What happened to Symbio Pharmaceuticals Limited’s price movement after its last earnings report?
Symbio Pharmaceuticals Limited reported an EPS of -¥16.72 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.174%.
Which hedge fund is a major shareholder of Symbio Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in JP:4582
---
Symbio Pharmaceuticals Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technical Analysis
Chiome Bioscience Inc.
―
Kidswell Bio Corporation
―
Medrx Co., Ltd.
―
Oncolys BioPharma, Inc.
―
---